ABVC Earnings

Quarterly EPS
$-0.06
Q4 2024
$-0.06
Q1 2025
$-0.13
Q2 2025
$-0.09
Q3 2025
$0.00
Q4 2025
$-0.06
Q1 2026
$-0.03
Q2 2026
$0.04
Q3 2026
Latest RevenueN/A
Latest Net Income-1390132
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026$0.040-1390132—+144.4%
Q2 2026-$0.030-810481—+76.9%
Q1 2026-$0.060-1689937—+0.0%
Q4 2025—————
Q3 2025-$0.090-2083473-100.0%-200.0%
Q2 2025-$0.130-2332833-100.0%-62.5%
Q1 2025-$0.060-944190-100.0%+79.3%
Q4 2024-$0.062.0K-796527-9.2%+0.0%
Q3 2024-$0.03389.3K-487431——
Q2 2024-$0.08117.1K-1047412——
Q1 2024-$0.291.2K-2927667——
Q4 2023-$0.062.2K-700309——
ABVC BioPharma (ABVC) — Earnings